Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Luxiq betamethasone valerate: Phase IV data; marketed to treat dermatoses of the scalp

In a 37-patient U.S. Phase IV trial, twice daily applications of

Read the full 119 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE